Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans체질량 지수와 COVID-19 진단, 입원 및 사망 위험: 2 524 926 카탈로니아인에 대한 코호트 연구Clinical Research Article Published on 2021-07-232022-09-12 Journal: The Journal of Clinical Endocrinology and Metaboli [Category] MERS, 진단, [키워드] 95%CI Adiposity age and sex association BMI BMIs body mass body mass index Care cohort study Context COVID-19 COVID-19 diagnosis death diagnosed diagnosed with COVID-19 Diagnosis Electronic health records fatality Follow-up hazard hazard ratios Height higher risk hospital hospitalisation hospitalisation with COVID-19 hospitalised increase in individual mechanism Modification Mortality obesity objective outcome outcome measure participant Participants Research Result risk risk of COVID-19 SARS-CoV-2 setting subsequent weight with COVID-19 younger patients [DOI] 10.1210/clinem/dgab546 PMC 바로가기 [Article Type] Clinical Research Article
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic populationPublic Health Published on 2021-07-232022-10-28 Journal: BMJ Open [Category] COVID-19, Fulltext, SARS, [키워드] adjusted relative risk Adjusting Anxiety aRR association Cohort Comorbidities covariate COVID-19 COVID-19 severity cross-sectional Depression diagnosis of COVID-19 disease course disorder DSM-5 Epidemiology exacerbated highest hospital hospitalised Iceland illness Illness severity increased risk individual lowest media Mental mental health morbidities morbidity multivariable objective Older outcome measure participant Patient Poisson regression Posttraumatic Stress PTSD public health recovering from COVID-19 recruited Result risk scale Screen setting severity symptom burden symptoms of depression thresholds was used [DOI] 10.1136/bmjopen-2021-049967 PMC 바로가기 [Article Type] Public Health
Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patientsResearch Published on 2021-07-232022-10-28 Journal: BMC Nephrology [Category] COVID-19, [키워드] Acute kidney injury addition adjusted hazard ratio adjusted odds ratio Admission AKI Atrial fibrillation C-reactive protein Chronic kidney disease CKD Community Community-acquired coronavirus disease COVID-19 Cox regression CRP death diabetes eligible patient frailty hospital Hospital-acquired hospitalised hospitalised COVID-19 patient hospitalised COVID-19 patients incidence independent risk factor Injury Invasive mechanical ventilation Kidney injury lymphocyte mechanism Mortality occurred Patient positive COVID-19 protective effect recorded reported respiratory rate Result returned risk factor Risk factors Significant significantly significantly higher stratified Swab Systolic blood pressure the timing was collected with COVID-19 [DOI] 10.1186/s12882-021-02471-2 PMC 바로가기 [Article Type] Research
Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021COVID-19 물리적 거리두기 조치가 완화된 후 어린이의 호흡기 세포융합 바이러스 전염병 지연, 이스라엘 아슈도드, 2021Rapid Communication Published on 2021-07-222022-09-10 Journal: Eurosurveillance [Category] SARS, 치료제, [키워드] administration Ashdod children COVID-19 COVID-19 pandemic Delayed Epidemic Health hospitalised implication incidence incidence rates include Infection outbreak palivizumab palivizumab administration physical distancing physical distancing measures Public public health measures re-evaluation Relaxation respiratory syncytial virus respiratory syncytial virus (RSV) resurgence RSV seasonality severity socioeconomic status summer [DOI] 10.2807/1560-7917.ES.2021.26.29.2100706 PMC 바로가기 [Article Type] Rapid Communication
Regional variation in COVID-19 positive hospitalisation across Scotland during the first wave of the pandemic and its relation to population density: A cross-sectional observation studyObservational Study Published on 2021-07-092022-10-04 Journal: PLoS ONE [Category] MERS, SARS, 임상, [키워드] accounted age approach COVID-19 COVID-19 hospitalisation COVID-19 positive patient COVID-19 virus cross-sectional death Deprivation expressed Final First wave had more Health hospitalisation hospitalised Hospitalised patients introduced Linear regression analysis lockdown Measures median median age Multiple National NHS observation pandemic peaked performed positive prevalence study Prevent Regional repeated rising Scottish significantly statistically significant Support Variation [DOI] 10.1371/journal.pone.0253636 PMC 바로가기 [Article Type] Observational Study
An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 20212021년 4월 영국 런던에서 COVID-19 백신 Vaxzevria의 단일 용량으로 부분 백신 접종을 한 후 요양원에서 SARS-CoV-2 Delta(B.1.617.2) 변종으로 인한 발병Rapid Communication Published on 2021-07-082022-09-10 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] AstraZeneca attack rate B.1.617.2 B.1.617.2 variant Care care home outbreaks caused ChAdOx1 ChAdOx1 vaccine ChAdOx1-S COVID-19 COVID-19 outbreak COVID-19 vaccine Delta delta variant died England hospitalised individual investigated London outbreak SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections single dose the SARS-CoV-2 vaccination Vaccine vaccine dose vaccine effectiveness variant Vaxzevria [DOI] 10.2807/1560-7917.ES.2021.26.27.2100626 PMC 바로가기 [Article Type] Rapid Communication
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial입원한 COVID-19 환자의 개선에 대한 재조합 에리트로포이에틴의 효능 및 안전성 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-07-062022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 48 hours Adverse reaction Adverse reactions age approved Arm Bandar Abbas Blinding block randomization blood pressure Care checked chronic lung disease clinical clinical symptom clinical trial clinical trials Committee company comparator Patients composite endpoint control group Controlled clinical trial controls Coronary heart disease COVID-19 COVID-19 patient COVID-19 patients CRP Deep vein Deep vein thrombosis diabetes Diabetes Mellitus Diastolic blood pressure dissemination distilled water Efficacy and safety element End-stage renal disease endogenous enoxaparin erythropoietin ethics committee evaluate evaluate the effect excluded exclusion criteria expected Haemoglobin Health Health care heart disease hospitalised hospitalised COVID-19 patients Hypoxemia immune system infiltration injection intervals Intervention intervention group investigator Iran Laboratory test Laboratory tests LDH Liver disease Local Lung disease lung field lung infiltration lymphocyte Lymphocyte count lymphopenia Medical Science Medical Sciences medication minute number objective oral contraceptive outcome oxygen oxygen partial pressure oxygen saturation parallel-group partial pressure participant Patient PCR performed pharmaceutical Pharmaceutical Company Phase 2 Placebo positive Prevent principal investigator protocol randomised randomised controlled trial Randomized Randomly receive recombinant erythropoietin recruitment Registered registry renal disease reported respiratory respiratory rate Sample size saturation severe COVID-19 symptom severe COVID-19 symptoms Side effect Side effects Standard Standard of care status sterile water Study protocol subcutaneous injection subject supplementary material Systolic blood pressure tachypnea technology the ethics committee thrombosis title Treatment protocol treatment protocols Trial registration university vital signs water water for injection weakened immune system website [DOI] 10.1186/s13063-021-05363-w PMC 바로가기 [Article Type] Letter
Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19Research Article Published on 2021-07-032022-10-27 Journal: BMC Public Health [Category] COVID-19, [키워드] absence adjusted age appear association cardiovascular disease cardiovascular risk factor cardiovascular risk factors Care cohort study Comorbidities conducted COVID-19 CV complication CV complications CVD diabete diabetes disease Follow-up hospitalised hypertension in-hospital mortality independent male median age Mortality MOST occurred Older Patient Result risk factor Risk factors severe COVID-19 supplementary material susceptibility Venous Thromboembolism VTE with COVID-19 [DOI] 10.1186/s12872-021-02137-9 PMC 바로가기 [Article Type] Research Article
Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19Research Article Published on 2021-07-032022-10-27 Journal: BMC Public Health [Category] Coronavirus, COVID-19, SARS, [키워드] absence adjusted age appear association cardiovascular disease cardiovascular risk factor cardiovascular risk factors Care cohort study Comorbidities conducted COVID-19 CV complication CV complications CVD diabete diabetes disease Follow-up hospitalised hypertension in-hospital mortality independent male median age Mortality MOST occurred Older Patient Result risk factor Risk factors severe COVID-19 supplementary material susceptibility Venous Thromboembolism VTE with COVID-19 [DOI] 10.1186/s12872-021-02137-9 PMC 바로가기 [Article Type] Research Article
Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: Results of a multicenter national survey교정 QT 간격 및 Torsade de Pointes 유도에 대한 COVID-19 약물의 영향: 다기관 국가 조사 결과Multicenter Study Published on 2021-07-012022-09-11 Journal: International journal of clinical practice [Category] SARS, 치료제, [키워드] addressed administration Amiodarone arrhythmia Atazanavir Azithromycin Chloroquine Cohort Combination combination therapy coronavirus coronavirus disease COVID-19 COVID-19 patient Critical death demonstrated during treatment Effect Favipiravir female gender furosemide heart failure hepatic dysfunction hospital hospitalised Hydroxychloroquine hypokalaemia incidence inclusion criteria Iran life-threatening Lopinavir Lopinavir-ritonavir Lopinavir/ritonavir medication medications multicenter National occurred oseltamivir Patient patients predicted Primary outcome Prospective Study QT interval QT prolongation QTc QTC prolongation Remdesivir renal reported Repurposed drug Repurposed drugs Result risk Ritonavir secondary outcome Secondary outcomes Side effect therapy Torsade de Pointes treated Treatment [DOI] 10.1111/ijcp.14182 PMC 바로가기 [Article Type] Multicenter Study